MyFinsight
Home
Blog
About
Short-term investments
$81,953K
(-19.52%↓ Y/Y)
Cash and cash
equivalents
$6,803K
(18.50%↑ Y/Y)
Prepaid expenses and
other current assets
$4,335K
(13.07%↑ Y/Y)
Total current assets
$93,091K
(-16.44%↓ Y/Y)
In-process research and
development
$32,386K
(0.00%↑ Y/Y)
Operating lease asset, net
$445K
(-42.43%↓ Y/Y)
Other assets
$172K
(-50.29%↓ Y/Y)
Total assets
$126,094K
(-12.98%↓ Y/Y)
Total liabilities,
convertible preferred stock...
$126,094K
(-12.98%↓ Y/Y)
Total liabilities
$54,063K
(39.05%↑ Y/Y)
Convertible preferred
stock, value-Series...
$36,867K
(-31.15%↓ Y/Y)
Total stockholders
equity
$33,013K
(-34.41%↓ Y/Y)
Convertible preferred
stock, value-Series...
$2,151K
(0.00%↑ Y/Y)
Accumulated deficit
-$471,858K
(-26.40%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$114K
(-137.50%↓ Y/Y)
Warrant liabilities
$40,001K
(77.69%↑ Y/Y)
Total current
liabilities
$11,789K
(-14.07%↓ Y/Y)
Deferred tax liabilities
$2,187K
(0.18%↑ Y/Y)
Non-current operating lease
liabilities
$86K
(-81.58%↓ Y/Y)
Additional paid-in capital
$504,904K
(19.19%↑ Y/Y)
Common stock, 0.001 par
value, 450,000,000...
$81K
(35.00%↑ Y/Y)
Accrued expenses and
other liabilities
$8,194K
(8.50%↑ Y/Y)
Accounts payable
$3,214K
(-44.88%↓ Y/Y)
Current operating lease
liabilities
$381K
(13.39%↑ Y/Y)
Back
Back
Balance Sheet
Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. (ELDN)
source: myfinsight.com